Table 2.
Univariate and Multivariate Analyses of Clinicopathologic Characteristics for DFS in Diffuse Large B-Cell Lymphoma
| Univariate Analysis | Multivariate Analysis | |||
|---|---|---|---|---|
| Variable | HR (95% CI) | P-value | HR(95% CI) | P-value |
| GLUT-3 | 2.074 (1.033–4.167) | 0.040 | 2.255(1.083–4.693) | 0.030 |
| IPI | 1.845 (1.108–3.073) | 0.019 | 1.208 (0.463–3.151) | 0.700 |
| Ki-67 | 1.171 (0.663–2.067) | 0.587 | 0.922 (0.499–1.705) | 0.795 |
| Sex | 1.169 (0.647–2.112) | 0.605 | 1.377 (0.740–2.562) | 0.312 |
| Age | 1.418 (0.804–2.499) | 0.227 | 1.811 (0.918–3.574) | 0.087 |
| Ann Arbor stage | 1.674 (0.942–2.977) | 0.079 | 1.691 (0.744–3.841) | 0.210 |
| Number of extranodal sites | 1.461 (0.719–2.970) | 0.294 | 1.046 (0.366–2.988) | 0.934 |
Abbreviations: GLUT-3, glucose transporter 3; IPI, international prognostic index.